(Press-News.org) A pioneering international survey of people living with eating disorders has found that cannabis and psychedelics, such as ‘magic mushrooms’ or LSD, were best rated as alleviating symptoms by respondents who self-medicated with the non-prescribed drugs.
The worst-rated drugs were alcohol, tobacco, nicotine and cocaine.
Prescribed drugs, such as antidepressants, were generally not well rated for treating eating-disorder symptoms but were positively rated for effects on general mental health.
The research, led by PhD student Sarah-Catherine Rodan at the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics, is published today in JAMA Network Open.
Ms Rodan said: “Our results provide important insights into the lived experiences of people with eating disorders and their drug use, highlighting promising avenues for future research into treatments.
“The findings suggest more research, including large clinical trials, should be undertaken around the beneficial effects of cannabis and psychedelics for people with eating disorders.”
The Lambert Initiative researchers will shortly launch a clinical trial of psilocybin in treating anorexia nervosa in collaboration with the Inside Out Institute at the University of Sydney.
Scope and response of survey
The study analysed responses from over 7600 self-allocated participants in 83 countries, making it the most comprehensive survey ever conducted on this topic.
The research focused on how people with different types of eating disorders use prescription and non-prescription drugs, and how they perceive these substances’ effects on their mental health and eating disorder symptoms.
The major categories of eating disorders were well-represented in the survey: anorexia nervosa (40%); bulimia nervosa (19%); binge-eating disorder (11%); and avoidant/restrictive food intake disorder (ARFID) (9%). About one third of respondents were not formally diagnosed with an eating disorder but self-reported an eating disorder that caused distress.
Co-morbid mental health conditions, which are often found in these populations, were frequently reported including depression (65%), generalised anxiety disorder (55%), ADHD (33%), drug dependence (15%) and alcohol dependence (9%).
Respondents were predominantly female (94%), with most from English-speaking places, like Australia (30%), the UK (21.3%) and the US (18%).
The results revealed patients with eating disorders have high rates of cannabis and psychedelic use relative to the general populations and rate their effects positively in terms of managing symptoms. Notably, cannabis was highly rated by respondents with restrictive eating disorders such as anorexia and ARFID, most likely because it enhances the rewarding value of food, addressing a core issue in these eating disorders.
In contrast, prescription stimulants such as lisdexamfetamine, which have strong appetite suppressing effects and are sometimes prescribed for binge eating disorder (BED), were positively rated by people with BED but poorly rated by those with restrictive type disorders.
Psychedelics, typically only taken once or twice a year by respondents, were reported to have remarkable long-lasting benefits, supporting recent research showing their therapeutic potential in treating conditions such as depression and anxiety. Conversely, commonly prescribed medications – such as antidepressants – which are typically taken daily, were generally rated as relatively ineffective for reducing ED symptoms but were widely acknowledged to help with overall mental health.
The survey also found that drugs like alcohol, nicotine, and cocaine, although quite widely used, led to negative outcomes on eating disorder symptoms and general mental health.
Ms Rodan said: "These findings highlight an important pattern: with traditional medications often falling short in treating eating disorders directly, while many individuals are self-medicating with substances they perceive as helpful. This underlines the urgent need to better investigate these substances in rigorously controlled clinical trials.”
Next steps: clinical trials
The insights gained by this study have already prompted further research initiatives. The Lambert Initiative, in collaboration with the Inside Out Institute at the University of Sydney, is preparing to launch a clinical trial of psilocybin in treating anorexia nervosa. Additionally, a pilot study examining the therapeutic potential of the non-intoxicating cannabis component, cannabidiol (CBD), in treating severe anorexia in young people, is nearing completion.
Professor Iain McGregor, the senior author on this paper and Academic Director of the Lambert Initiative, said: “This research suggests that cannabis and psychedelics hold significant promise for improving quality of life in individuals suffering eating disorders. This is particularly salient since current pharmacological options for these patients are severely limited and current treatment outcomes so disappointing.
“Of course, rigorous clinical trials are needed to confirm these benefits and better determine safety profiles.”
Ms Rodan said: “I hope this study gives a voice to people living with eating disorders, revealing that their often-stigmatised experiences with drugs might in fact have therapeutic potential. We are extremely grateful to the many thousands of respondents who took the time to provide such detailed responses around their lived experiences. This should spur further research and open new treatment pathways for these challenging conditions.”
Interviews
Professor Iain McGregor | iain.mcgregor@sydney.edu.au
Sarah-Catherine Rodan | sarah-catherine.rodan@sydney.edu.au
(NB: both researchers are currently in the UK, so be aware of time zone differences)
Media Contact
Marcus Strom | marcus.strom@sydney.edu.au | +61 474 269 459
Research
Rodan, S. et al ‘Prescription and Nonprescription Drug Use Among People With Eating Disorders’ (JAMA Network Open, July 2025). DOI: 10.1001/jamanetworkopen.2025.22406
Declaration
The study was funded by the Lambert Initiative for Cannabinoid Therapeutics, a philanthropically funded research program at the University of Sydney. Researchers report funding support from the National Health and Medical Research Council of Australia. Dr Anastasia Suraev reports consulting fees from the Medicinal Cannabis Industry Australia (MCIA). Professor Iain McGregor receives fees from Althea, Jannssen and the MCIA. He also has share options with Kinoxis Therapeutics, consultancies with Psylo and Emyria and patents with Kinoxis.
END
Psychedelics and cannabis offer treatment hope for people with eating disorders
Largest global study into self-medicated treatments reveal surprising results
2025-07-22
ELSE PRESS RELEASES FROM THIS DATE:
Answer ALS launches AI drug development collaboration with GATC Health, Pennington Biomedical Research Center, and Tulane to advance ALS treatment discovery
2025-07-22
NEW ORLEANS, July 22, 2025 — Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative aimed at accelerating AI-powered drug discovery for ALS and other neurodegenerative diseases. This effort, known as the Louisiana AI Drug Development Infrastructure for ALS (LADDIA), brings together leading institutions and innovators, including GATC Health, Pennington Biomedical Research Center, and Tulane University — a tech-bio innovator using validated AI models to accelerate drug discovery from large-scale multiomics data — to harness the power of artificial ...
Restricted diet triggers individualized microbiome shifts without community convergence
2025-07-22
How much can six days of eating just oats, milk, and water change your gut microbiome?
According to a recent exploratory study published in eGastroenterology, the answer is more complex than expected. Researchers from KU Leuven and collaborating institutions conducted a tightly controlled dietary intervention, known as the "Oatmeal Study", to examine whether restricting food variety could induce convergence in the gut microbiota across individuals. Surprisingly, while participants' diets became nearly identical, their microbiomes did not follow suit. It ...
How tickling builds trust: Scientists identify oxytocin’s role in human-rat bonding
2025-07-22
Pleasant tactile stimulation drives social bonding in many animal species, especially mammals. Tactile stimulation forms the basis of the infant-caregiver relationship and often leads to affinity-like behavior, indicating the formation of social bonds. Juvenile-adolescent rats often engage in rough-and-tumble play, during which they emit characteristic ultrasonic vocalizations. These vocalizations, typically in the 50 kHz frequency range, are thought to be associated with pleasurable emotional states. Juvenile adolescent rats also emit 50 kHz ultrasonic vocalizations in response to tickling with human hands, which mimics natural rough-and-tumble play. Moreover, these rats develop a ...
LAHB: A bioplastic that may solve marine plastic pollution problem
2025-07-22
Researchers have demonstrated a new eco-friendly plastic that decomposes in deep ocean conditions. In a deep-sea experiment, the microbially synthesized poly(d-lactate-co-3-hydroxybutyrate) (LAHB) biodegraded, while conventional plastics such as a representative bio-based polylactide (PLA) persisted. Submerged 855 meters underwater, LAHB films lost over 80% of their mass after 13 months as microbial biofilms actively broke down the material. This real-world test establishes LAHB as a safer biodegradable plastic, supporting global efforts to reduce marine plastic waste. ...
The Holobiont Revolution: How wheat is becoming more climate-resilient through nature-based plant breeding and machine learning
2025-07-22
Nitrogen fertilizers used in agriculture contribute significantly to global warming. A new breeding concept, specifically for wheat, could help reduce nitrogen fertilization. This holobiont principle places the complex interactions between plants and soil microbiomes at the center of plant breeding. In combination with machine learning, this could lead to the use of new wheat varieties, as well as other crops, that are more resilient to climate change and contribute to soil health. Two recent studies led by Wolfram Weckwerth from the University of Vienna have been published in the journals Plant Biotechnology and Trends in Plant Science.
To increase the supply ...
International radiology consensus outlines best practices for post-COVID CT
2025-07-22
OAK BROOK, Ill. – Experts representing multiple societies and institutions across 14 countries have published guidance for computed tomography (CT) imaging in patients with residual lung abnormalities after COVID-19 illness. The consensus statement appears today in Radiology, a journal of the Radiological Society of North America (RSNA).
The statement’s authors seek to standardize the indications for when chest CT is appropriate for patients with post–COVID-19 condition, the methods for acquiring images and the terminology used for reporting residual ...
Yellowstone aspen showing signs of recovery following 1995 reintroduction of wolves to park
2025-07-22
CORVALLIS, Ore. – Yellowstone National Park is celebrating an ecological milestone along with a key anniversary this summer, Oregon State University researchers report.
A paper published today in Forest Ecology and Management documents the first new generation of overstory aspen trees in Yellowstone’s northern range in 80 years, three decades after wolves were reintroduced to the nation’s oldest national park.
Without predation pressure from wolves, which had been extirpated from the park by 1930, elk populations grew to the point that their browsing was thwarting the growth of young aspen. The ecosystem effects ...
Post-COVID-related lung abnormalities almost always regress
2025-07-22
Visible on chest CT scans, post-COVID-19 residual lung abnormalities, which affect up to 50% of patients who have had an infection requiring hospitalization, may be associated with persistent or progressive respiratory symptoms and are often related to changes in respiratory function tests. But unlike other non-infectious abnormalities, they tend to stabilize or regress over time, indicating that they are non-progressive and only post-infectious in nature.
Published in the journal Radiology, the paper is the result of a multi-society consensus statement developed by 21 chest radiologists belonging to the European Society of Thoracic Imaging (ESTI), the Society ...
City of Hope research spotlight, June 2025
2025-07-22
LOS ANGELES — City of Hope® Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, life-threatening diseases. Each spotlight features research-related news, such as recognitions, collaborations and the latest research defining the future of medical treatment.
This roundup highlights a new drug combination that slows the spread of advanced prostate cancer, a novel artificial intelligence (AI) conversation ...
SwRI completes 8-year-long NEXTCAR energy efficiency project
2025-07-22
SAN ANTONIO — July 22, 2025 — Southwest Research Institute (SwRI) has successfully completed its ambitious eight-year-long connected and automated (CAV) vehicle technology project.
As part of the Advanced Research Projects Agency-Energy’s (ARPA-E) NEXTCAR (NEXT-Generation Energy Technologies for Connected and Automated On-Road Vehicles) program, SwRI developed an automated vehicle that combines CAV technology and SAE Level 4 automation to demonstrate up to 30% energy savings compared to traditional hybrid vehicles, without modifications to the powertrain hardware. The completed SwRI ...
LAST 30 PRESS RELEASES:
Lizard genetics provide new perspective on evolution
Can a Stevia-derived sweetener improve hair loss treatment?
Method to assess the status of wild reindeer may help with conservation efforts
Do imported cut flowers spread livestock viruses?
Does prior incarceration contribute to poor health later in life?
Could slime mold microbes be a source of potent antimicrobials?
Record-breaking 2024 Amazon fires drive unprecedented carbon emissions and ecosystem degradation
Birds thrive despite pollution from ‘forever’ chemicals
Deadwood brings wild orchids to life
Changes in gut microbiota influence which patients get AIG-related neuroendocrine tumors
Medicaid expansion linked to improved long-term survival in cancer patients
Women with surgical menopause may exit workforce earlier, but hormone therapy could help
Trailblazing Young Scientists honored with $250,000 prizes at Blavatnik National Awards Gala
Revolutionary blood test for ME / Chronic Fatigue unveiled
Calorie labelling linked to 2% average reduction in energy content of menu items
Widely prescribed opioid painkiller tramadol not that effective for easing chronic pain
Exercise snacks may boost cardiorespiratory fitness of physically inactive adults
15,000 women a year with breast cancer could benefit from whole genome sequencing, say researchers
Study highlights risks of Caesarean births to future pregnancies
GLP-1 agonists pose emerging challenge for PET-CT imaging, study finds
Scripps Research scientists unlock new patterns of protein behavior in cell membranes
Panama Canal may face frequent extreme water lows in coming decades
Flash Joule heating lights up lithium extraction from ores
COMBINEDBrain and MUSC announce partnership to establish biorepository for pediatric cerebrospinal fluid and CNS tissue bank
Questionable lead reporting for drinking water virtually vanished after Flint water crisis, study reveals
Assessing overconfidence among national security officials
Bridging two frontiers: Mitochondria & microbiota, Targeting Extracellular Vesicles 2025 to explore game-changing pathways in medicine
New imaging tech promises to help doctors better diagnose and treat skin cancers
Once dominant, US agricultural exports falter amid trade disputes and rising competition
Biochar from invasive weed shields rice from toxic nanoplastics and heavy metals
[Press-News.org] Psychedelics and cannabis offer treatment hope for people with eating disordersLargest global study into self-medicated treatments reveal surprising results